GLG1 plasma levels significantly discriminated patients from controls samples (mean ± SEM = 863.65 ± 146.21 pg/mL for the pathological group -premalignant individuals and CRC patients- versus 412.26 ± 39.82 pg/mL for controls; p-value = 0.0043) (Figure 7A). This evidence concerns the gene GLG1 and colorectal carcinoma.